Sándor Szántó

3.1k total citations
81 papers, 2.3k citations indexed

About

Sándor Szántó is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Sándor Szántó has authored 81 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Rheumatology, 21 papers in Immunology and 14 papers in Molecular Biology. Recurrent topics in Sándor Szántó's work include Rheumatoid Arthritis Research and Therapies (36 papers), Spondyloarthritis Studies and Treatments (25 papers) and Systemic Lupus Erythematosus Research (21 papers). Sándor Szántó is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (36 papers), Spondyloarthritis Studies and Treatments (25 papers) and Systemic Lupus Erythematosus Research (21 papers). Sándor Szántó collaborates with scholars based in Hungary, United States and United Kingdom. Sándor Szántó's co-authors include Zoltán Szekanecz, Katalin Mikecz, Tibor T. Glant, Gabriella Szűcs, Tamás Bárdos, István Gál, Rajesh V. Kamath, Gabriella Lakos, Nóra Bodnár and Sándor Sipka and has published in prestigious journals such as The Journal of Immunology, Development and Annals of the New York Academy of Sciences.

In The Last Decade

Sándor Szántó

79 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sándor Szántó Hungary 29 1.1k 881 506 239 215 81 2.3k
Yasushi Miura Japan 30 616 0.6× 550 0.6× 750 1.5× 111 0.5× 164 0.8× 121 2.9k
Carolina Llanos Chile 23 890 0.8× 751 0.9× 304 0.6× 115 0.5× 303 1.4× 38 1.9k
Elena Peeva United States 31 1.2k 1.1× 1.2k 1.4× 255 0.5× 153 0.6× 85 0.4× 96 3.1k
Antonio Manzo Italy 30 1.3k 1.2× 1.2k 1.3× 449 0.9× 246 1.0× 79 0.4× 72 3.0k
So‐Young Bang South Korea 24 846 0.8× 593 0.7× 442 0.9× 128 0.5× 111 0.5× 100 1.8k
Clio P. Mavragani Greece 36 1.5k 1.3× 1.2k 1.4× 617 1.2× 186 0.8× 222 1.0× 154 4.0k
Norbert Sepp Austria 35 824 0.7× 1.2k 1.3× 794 1.6× 296 1.2× 82 0.4× 115 3.5k
B. P. Wordsworth United Kingdom 27 990 0.9× 883 1.0× 284 0.6× 244 1.0× 52 0.2× 52 2.0k
Maria Grazia Sabbadini Italy 35 1.1k 1.0× 1.9k 2.2× 697 1.4× 322 1.3× 67 0.3× 87 3.5k
Shinsuke Yasuda Japan 32 1.8k 1.6× 993 1.1× 474 0.9× 1.1k 4.4× 74 0.3× 163 3.2k

Countries citing papers authored by Sándor Szántó

Since Specialization
Citations

This map shows the geographic impact of Sándor Szántó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sándor Szántó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sándor Szántó more than expected).

Fields of papers citing papers by Sándor Szántó

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sándor Szántó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sándor Szántó. The network helps show where Sándor Szántó may publish in the future.

Co-authorship network of co-authors of Sándor Szántó

This figure shows the co-authorship network connecting the top 25 collaborators of Sándor Szántó. A scholar is included among the top collaborators of Sándor Szántó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sándor Szántó. Sándor Szántó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Végh, Edit, Ágnes Horváth, Attila Hamar, et al.. (2021). Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology. Biomolecules. 11(10). 1535–1535. 10 indexed citations
2.
Kucharz, Eugeniusz J., Sándor Szántó, Mariana Ivanova, et al.. (2019). Endorsement by Central European experts of the revised ESCEO algorithm for the management of knee osteoarthritis. Rheumatology International. 39(7). 1117–1123. 19 indexed citations
3.
Póliska, Szilárd, Tímea Besenyei, Edit Végh, et al.. (2019). Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis. Arthritis Research & Therapy. 21(1). 94–94. 9 indexed citations
4.
Végh, Edit, Péter Csomor, Szilvia Szamosi, et al.. (2016). Evaluation of the immunogenicity of the 13-valent conjugated pneumococcal vaccine in rheumatoid arthritis patients treated with etanercept. Joint Bone Spine. 83(6). 675–679. 31 indexed citations
5.
Baji, Petra, Márta Péntek, Sándor Szántó, et al.. (2014). Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis. The European Journal of Health Economics. 15(S1). 45–52. 29 indexed citations
6.
Bodnár, Nóra, et al.. (2013). Treatment of ankylosing spondylitis with biologics and targeted physical therapy. Zeitschrift für Rheumatologie. 72(10). 997–1004. 13 indexed citations
7.
Szekanecz, Zoltán, Edit Végh, Andrea Váncsa, et al.. (2012). Vascular rheumatology: atherosclerosis and cardiovascular disease in arthritis. Reumatologia/Rheumatology. 50(4). 336–344. 1 indexed citations
8.
Bodnár, Nóra, Zoltán Szekanecz, Zoltán Prohászka, et al.. (2011). Anti-mutated citrullinated vimentin (anti-MCV) and anti-65kDa heat shock protein (anti-hsp65): New biomarkers in ankylosing spondylitis. Joint Bone Spine. 79(1). 63–66. 26 indexed citations
9.
Glant, Tibor T., Sándor Szántó, Ákos Végvári, et al.. (2008). Two Loci on Chromosome 15 Control Experimentally Induced Arthritis through the Differential Regulation of IL-6 and Lymphocyte Proliferation. The Journal of Immunology. 181(2). 1307–1314. 10 indexed citations
10.
Sipka, Sándor, Ildikó Kovács, Sándor Szántó, et al.. (2007). Adenosine inhibits the release of arachidonic acid and its metabolites (AAM) in activated human peripheral mononuclear cells. Inflammation Research. 56(11). 468–472. 5 indexed citations
11.
Szekanecz, Zoltán, Lilla Soós, Zoltán Szabó, et al.. (2007). Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis: As Good as it Gets?. Clinical Reviews in Allergy & Immunology. 34(1). 26–31. 58 indexed citations
12.
Szekanecz, Zoltán, György Kerekes, Zsuzsa Sándor, et al.. (2007). Accelerated Atherosclerosis in Rheumatoid Arthritis. Annals of the New York Academy of Sciences. 1108(1). 349–358. 83 indexed citations
13.
Végvári, Ákos, Zoltán Szabó, Sándor Szántó, et al.. (2005). Two Major Interacting Chromosome Loci Control Disease Susceptibility in Murine Model of Spondyloarthropathy. The Journal of Immunology. 175(4). 2475–2483. 16 indexed citations
14.
Gál, István, et al.. (2005). Visualization and in situ analysis of leukocyte trafficking into the ankle joint in a systemic murine model of rheumatoid arthritis. Arthritis & Rheumatism. 52(10). 3269–3278. 27 indexed citations
15.
Sipka, Sándor, Ildikó Kovács, Sándor Szántó, et al.. (2005). Adenosine inhibits the release of interleukin-1β in activated human peripheral mononuclear cells. Cytokine. 31(4). 258–263. 38 indexed citations
16.
Szántó, Sándor, et al.. (2004). Expression of L-Selectin, but Not CD44, Is Required for Early Neutrophil Extravasation in Antigen-Induced Arthritis. The Journal of Immunology. 172(11). 6723–6734. 33 indexed citations
17.
18.
19.
Sipka, Sándor, Sándor Szántó, Ildikó Kovács, et al.. (2000). Inhibition of calcineurin activity and protection against cyclosporine A induced cytotoxicity by prednisolone sodium succinate in human peripheral mononuclear cells. Immunopharmacology. 48(1). 87–92. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasushi Miura Breakdown of academic impact, for papers by Carolina Llanos Breakdown of academic impact, for papers by Elena Peeva Breakdown of academic impact, for papers by Antonio Manzo Breakdown of academic impact, for papers by So‐Young Bang Breakdown of academic impact, for papers by Clio P. Mavragani Breakdown of academic impact, for papers by Norbert Sepp Breakdown of academic impact, for papers by B. P. Wordsworth Breakdown of academic impact, for papers by Maria Grazia Sabbadini Breakdown of academic impact, for papers by Shinsuke Yasuda
Rankless by CCL
2026